(Q36457930)

14 August 2017

5 references

31 July 2019

27 November 2019

13 December 2019

15 December 2019

14 November 2020

Guidelines for the proper use of etanercept in Japan (English)

1 reference

disease-modifying antirheumatic drug

14 August 2017

cell surface receptor

1 reference

31 July 2019

1 reference

27 November 2019

1 reference

13 December 2019

1 reference

15 December 2019

1 reference

14 November 2020

1 reference

Nobuyuki Miyasaka

1

1 reference

14 August 2017

Tsutomu Takeuchi

series ordinal

2

1 reference

14 August 2017

Katsumi Eguchi

series ordinal

3

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

6 references

14 August 2017

31 July 2019

27 November 2019

13 December 2019

15 December 2019

14 November 2020

16

1 reference

14 August 2017

2

1 reference

14 August 2017

63-67

1 reference

https://scigraph.springernature.com/pub.10.1007/s10165-006-0457-7

14 August 2017

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Proposed [corrected] Japanese guidelines for the use of infliximab for rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779400

Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16633923

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16633923

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10165-006-0457-7

1 reference

release_we2q2df5dfdllbjw3vb7k5xm74

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/we2q2df5dfdllbjw3vb7k5xm74

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 August 2017

PubMed publication ID

16633923

1 reference